A new COPILOT function in Excel lets you use AI in a formula. The new skill is now available to Microsoft 365 insiders. Reduces some of the complexity involved in creating formulas. Get more in-depth ...

The Indian Council of Social Science Research (ICSSR) has issued a show cause notice to CSDS for alleged data manipulation related to election analysis, citing biased interpretations amid the ‘Vote ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Targovax ASA ( (GB:0RIS)) has issued an ...

PHILADELPHIA, PA — iECURE, Inc. will present new clinical data on its experimental gene therapy candidate, ECUR-506, at two international medical meetings in Kyoto, Japan, this September. The therapy ...

Copilot is on the way to Microsoft Excel. Or rather, more Copilot is being packed into the popular spreadsheet program. A new COPILOT function is rolling out now to users in the Beta Channel and ...

Mumbai: A day after Sanjay Kumar, the co-director of Lokniti-CSDS, ignited a political storm by withdrawing his posts on Maharashtra elections leading to criticism against Leader of the Opposition in ...

ABD-147 is a targeted radiopharmaceutical biologic therapy designed to deliver Actinium-225 (225Ac), a highly potent alpha-emitting radioisotope, to solid tumors expressing delta-like ligand 3 (DLL3) ...

PALO ALTO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio” or the "Company”), a new type of biopharmaceutical company focused on genetic diseases, ...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that it will present data from its rare epilepsy pipeline at the 36 th International Epilepsy ...

PALO ALTO, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, ...

MILAN, Aug. 28, 2025 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company developing next-generation gene therapies for inherited retinal diseases, today announced ...